Clinical stage biotechnology company Cynata Therapeutics has sealed a partnership agreement with Fujifilm as it makes a big step towards a commercial manufacturing deal for its proprietary Cymerus stem cell therapy products and eyes an accelerated push into the all-important United States market.Cynata is currently trialling its lead stem cell therapy product, known as CYP-001, as a treatment for a range of conditions, including heart attack and osteoarthritis. However it is elevating its focus
https://thewest.com.au/business/public-companies/cynata-seals-partnership-for-us-stem-cell-therapy-push-c-4113453
Cynata seals partnership for US stem cell therapy push
